These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

514 related articles for article (PubMed ID: 2198458)

  • 21. Cost-benefit analysis of two strategies for prevention of Haemophilus influenzae type b infection.
    Hay JW; Daum RS
    Pediatrics; 1987 Sep; 80(3):319-29. PubMed ID: 3114708
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prevention of bacterial meningitis. Vaccines and chemoprophylaxis.
    Lieberman JM; Greenberg DP; Ward JI
    Infect Dis Clin North Am; 1990 Dec; 4(4):703-29. PubMed ID: 2126022
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Conjugated vaccines against Haemophilus influenzae type b].
    Rümke HC; Poolman JT
    Ned Tijdschr Geneeskd; 1991 Jan; 135(1):4-7. PubMed ID: 2012643
    [No Abstract]   [Full Text] [Related]  

  • 24. [Type B Haemophilus influenzae infections. Experience at the Pediatric Hospital of Luxembourg].
    De Jonghe M; Glaesener G
    Bull Soc Sci Med Grand Duche Luxemb; 1995; 132(2):17-20. PubMed ID: 7497542
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Haemophilus influenzae type b. Conjugate vaccines for use in infants and children.
    Hanna JN; Steven ID; Plant AJ
    Aust Fam Physician; 1993 Jun; 22(6):1015-7, 1020-1. PubMed ID: 8338447
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Incidence of Haemophilus influenzae type b and other invasive diseases in South Korean children.
    Kim JS; Jang YT; Kim JD; Park TH; Park JM; Kilgore PE; Kennedy WA; Park E; Nyambat B; Kim DR; Hwang PH; Kim SJ; Eun SH; Lee HS; Cho JH; Kim YS; Chang SJ; Huang HF; Clemens JD; Ward JI
    Vaccine; 2004 Sep; 22(29-30):3952-62. PubMed ID: 15364444
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prevention of Haemophilus influenzae type b (Hib) meningitis and emergence of serotype replacement with type a strains after introduction of Hib immunization in Brazil.
    Ribeiro GS; Reis JN; Cordeiro SM; Lima JB; Gouveia EL; Petersen M; Salgado K; Silva HR; Zanella RC; Almeida SC; Brandileone MC; Reis MG; Ko AI
    J Infect Dis; 2003 Jan; 187(1):109-16. PubMed ID: 12508153
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [When should vaccination against Haemophilus influenzae type b take place?].
    Stickl HA
    Med Monatsschr Pharm; 1991 Jan; 14(1):24. PubMed ID: 2017108
    [No Abstract]   [Full Text] [Related]  

  • 29. Management of unimmunized contacts of patients with invasive Haemophilus disease.
    Sood SK; Daum RS
    Pediatr Infect Dis J; 1992 Feb; 11(2):134. PubMed ID: 1741190
    [No Abstract]   [Full Text] [Related]  

  • 30. Preventing Haemophilus influenzae type b disease.
    Casto DT; Edwards DL
    Clin Pharm; 1985; 4(6):637-48. PubMed ID: 3907936
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Disappearance of epiglottitis during large-scale vaccination with Haemophilus influenzae type B conjugate vaccine among children in Finland.
    Takala AK; Peltola H; Eskola J
    Laryngoscope; 1994 Jun; 104(6 Pt 1):731-5. PubMed ID: 8196448
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Immunogenicity of Haemophilus b conjugate vaccine (meningococcal protein conjugate) in children with prior invasive Haemophilus influenzae type b disease.
    Walter EB; Moggio MV; Drucker RP; Wilfert CM
    Pediatr Infect Dis J; 1990 Sep; 9(9):632-5. PubMed ID: 2235187
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The burden of Haemophilus influenzae type b disease in Australia and an economic appraisal of the vaccine PRP-OMP.
    Harris A; Hendrie D; Bower C; Payne J; de Klerk N; Stanley F
    Med J Aust; 1994 Apr; 160(8):483-8. PubMed ID: 8170423
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Haemophilus influenzae type b vaccines: lessons for the future.
    Ward JI; Broome CV; Harrison LH; Shinefield H; Black S
    Pediatrics; 1988 Jun; 81(6):886-93. PubMed ID: 3259307
    [No Abstract]   [Full Text] [Related]  

  • 35. Haemophilus influenzae type b prevention.
    N Y State J Med; 1989 Jul; 89(7):430-1. PubMed ID: 2788257
    [No Abstract]   [Full Text] [Related]  

  • 36. World-wide strategies for immunization against invasive Haemophilus influenzae type b disease.
    Iwarson S
    Vaccine; 1993; 11 Suppl 1():S28-9. PubMed ID: 8447169
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Continued shortage of Haemophilus influenzae Type b (Hib) conjugate vaccines and potential implications for Hib surveillance--United States, 2008.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2008 Nov; 57(46):1252-5. PubMed ID: 19023262
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Molecular epidemiology of Haemophilus influenzae type b.
    van Alphen L; Bijlmer HA
    Pediatrics; 1990 Apr; 85(4 Pt 2):636-42. PubMed ID: 2179853
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Update: prevention of Haemophilus influenzae type b disease.
    Centers for Disease Control (CDC)
    MMWR Morb Mortal Wkly Rep; 1986 Mar; 35(11):170-4, 179-80. PubMed ID: 3081787
    [No Abstract]   [Full Text] [Related]  

  • 40. Need for prevention of invasive Haemophilus influenzae type b infections in Geneva, Switzerland.
    Gervaix A; Suter S
    Vaccine; 1993; 11 Suppl 1():S34-7. PubMed ID: 8447172
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 26.